Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein...

Area of Science:

• Biochemistry and Structural Biology
• Nuclear Magnetic Resonance (NMR) Spectroscopy
• Drug Discovery and Medicinal Chemistry

Background:

• Saturation Transfer Difference (STD) NMR is a valuable technique in drug discovery for identifying ligand-binding epitopes within protein targets.
• Conventional STD NMR lacks the ability to provide detailed structural information about ligand-target interactions.
• Understanding ligand-target complex dynamics is crucial for optimizing small molecules in medicinal chemistry.

Purpose of the Study:

• To introduce and validate a novel integrated approach combining enhanced sampling methods with STD NMR experiments.
• To characterize ligand-target complexes dynamically, offering structural insights beyond conventional STD NMR.
• To demonstrate the utility of this approach in drug design by identifying exploitable features of a target protein.

Main Methods:

• Integration of enhanced sampling techniques with Saturation Transfer Difference (STD) NMR experiments.
• Application of the integrated approach to study the interaction between the antibacterial target StOASS-A and a known inhibitor.
• Computational modeling and experimental validation of ligand-target complex dynamics.

Main Results:

• The integrated approach provided a dynamic perspective on the ligand-target complex, overcoming limitations of traditional STD NMR.
• Identification of an accessory subpocket within the StOASS-A target, not previously recognized.
• Successful design and in vitro evaluation of novel StOASS-A inhibitors based on the identified subpocket, demonstrating expected activity.

Conclusions:

• The combined enhanced sampling and STD NMR approach offers a powerful tool for detailed characterization of ligand-target interactions.
• This methodology enables the discovery of novel binding sites and facilitates rational drug design, as exemplified by the StOASS-A inhibitor development.
• The findings pave the way for designing more effective therapeutics by exploiting previously uncharacterized binding pockets.